Effectiveness, safety and drug survival of tumor necrosis factor-α inhibitors in the treatment of spondyloarthritis: A real-life study in Tunisia

ConclusionAnti-TNFα therapy has a good response rate in SpA patients and an acceptable safety profile which explains the high drug survival rates.
Source: The Egyptian Rheumatologist - Category: Rheumatology Source Type: research